Assessment of psychological aspects during systemic provocation tests in patients with pseudoallergic drug reactions

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 7, 2006, Pages 800-803

  Hermes, B ^b   Hein, U R ^a   Henz, B Magdalena ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Vivantes   (Germany)

Author keywords

Anxiety; Drug reactions; Drug testing; Pseudo allergy; Psychological reactions

Indexed keywords

AMPICILLIN; LOCAL ANESTHETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ABDOMINAL PAIN; ANGINA PECTORIS; ANGIONEUROTIC EDEMA; ANXIETY DISORDER; ARTICLE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC TEST; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; DYSPNEA; ERYTHEMA; FATIGUE; FREQUENCY ANALYSIS; GASTROINTESTINAL SYMPTOM; HEADACHE; HEAT SENSATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; MEDICAL DOCUMENTATION; NAUSEA; NEUROLOGIC DISEASE; PHYSICIAN; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL ASPECT; RESPIRATORY TRACT DISEASE; RESTLESSNESS; SENSORY DYSFUNCTION; SIDE EFFECT; SKIN DISEASE; SWEATING; SYMPTOMATOLOGY; TACHYCARDIA; VALIDITY;

AMPICILLIN; ANESTHETICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANXIETY; DEPRESSION; DOUBLE-BLIND METHOD; DRUG HYPERSENSITIVITY; HUMANS; PERSONALITY ASSESSMENT; PSYCHOLOGICAL TESTS;

EID: 33746271919     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01634.x     Document Type: Article

References (21)

1. HoignéR, Lawson DH, Weber E. Risk factors for adverse drug reactions: Epidemiological approaches. Eur J Clin Pharmacol 1990; 39: 321-325.
2. Schlumberger HD. Pseudoallergic reactions to drugs and chemicals. Ann Allergy 1983; 51: 317-324.
3. Dukor P, Kallos P. Pseudo-Allergic Reactions. Karger, Basel, 1985.
4. Namazy JA, Simon RA. Sensitivity to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2002; 89: 542-550.
5. Nettis E, Colanardi MC, Ferrannini A, Tursi A. Update on sensitivity to nonsteroidal antiinflammatory drugs. Curr Drug Targets Immune Endocr Metabol Disord 2001; 1: 233-240.
6. Berkun Y, Ben-Zvi A, Levy Y et al. Evaluation of adverse reactions to local anesthetics: Experience with 236 patients. Ann Allergy Asthma Immunol 2003; 91: 319-320.
7. Wiedow O, Brasch J, Christophers E. Oral exposure testing in non-aspirin-induced analgesic intolerance. Hautarzt 1996; 47: 901-908.
8. Quiralte J, Blanco C, Castillo R et al. Intolerance to nonsteroidal antiinflammatory drugs: Results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 1996; 98: 678-685.
9. Gall H, Kaufmann R, Kalveram CM. Adverse reactions to local anesthetics. Analysis of 197 cases. J Allergy Clin Immunol 1996; 97: 933-9337.
10. Nettis E, Colanardi MC, Ferrannini A, Tursi A. Suspected tartrazine-induced acute urticaria/angioedema is only rarely reproducible by oral rechallenge. Clin Exp Allergy 2003; 33: 1725-1729.
11. Hein UR, Chantraine-Hess S, Worm M et al. Evaluation of systemic provocation tests in patients with suspected allergic and pseudoallergic drug reactions. Acta Derm Venereol 1999; 79: 139-142.
12. Gieler U, Kupfer J, Brosig B, Niemeier V. Psychosomatic aspects of allergy. Allergologie 2001; 7: 281-288.
13. Choy AC, Patterson R, Patterson DR et al. Undifferentiated somatoform idiopathic anaphylaxis: Nonorganic symptoms mimicking idiopathic anaphylaxis. J Allergy Clin Immunol 1995; 96: 893-900.
14. Hein UR, Henz BM, Haustein U et al. Correlation between chronic urticaria and depression/somatization disorder. Hautarzt 1995; 47: 20-23.
15. Pearce FL, Thompson HL. Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J Physiol (Lond) 1986; 372: 79-93.
16. Black PH. Stress and the inflammatory response: A review of neurogenic inflammation. Brain Behav Immun 2002; 16: 622-653.
17. Theoharides TC, Spanos C, Pang X et al. Stress-induced intracranial mast cell degranulation: A corticotropin-releasing hormone-mediated effect. Endocrinology 1995; 136: 5745-5750.
18. Grützkau A, Henz BM, Kirchhof L et al. α-Melanocyte stimulating hormone acts as a selective inducer of secretory functions in human mast cells. Biochem Biophys Res Commun 2000; 278: 14-19.
19. Wiesner-Menzel L, Schulz B, Vakilzadeh F, Czarnetzki BM. Electron microscopical evidence for a direct contact between nerve fibers and mast cells. Acta Derm Venereol 1981; 61: 465-469.
20. Russell M. Learned histamine release. Science 1984; 225: 733-734.
21. MacQueen G, Marshall J, Perdue M et al. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science 1989; 243: 83-85.